Global Metabolomics Market 2022-2028

The global metabolomics market is anticipated to increase by USD 12 billion till 2028 at an average annual growth of 11.8 percent.

Metabolomics is an analytical profiling technique for measuring and comparing large numbers of metabolites present in biological samples. Combining high-throughput analytical chemistry and multivariate data analysis, metabolomics offers a window on metabolic mechanisms. The global metabolomics market is anticipated to increase by USD 12 billion till 2028 at an average annual growth of 11.8 percent as per the latest report The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global metabolomics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the metabolomics industry.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, indication, application, and region. The global market for metabolomics can be segmented by product: assays, bioinformatics, detection techniques, separation techniques. The separation techniques segment is estimated to account for the largest share of the global metabolomics market. Metabolomics market is further segmented by indication: cancer, cardiovascular disorders, inborn errors of metabolism, neurological disorders, others. The cancer segment held the largest revenue share in 2021. Based on application, the metabolomics market is segmented into: biomarker discovery, drug discovery, functional genomics, nutrigenomics, toxicology testing, others. Globally, the biomarker discovery segment made up the largest share of the metabolomics market. On the basis of region, the metabolomics market also can be divided into: Asia Pacific, Europe, North America, MEA (Middle East and Africa), Latin America. North America was the largest contributor to the global metabolomics market in 2021. By product: - assays - bioinformatics - detection techniques - separation techniques By indication: - cancer - cardiovascular disorders - inborn errors of metabolism - neurological disorders - others

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Prashant Tiwari

Prashant Tiwari

Research Analyst

By application: - biomarker discovery - drug discovery - functional genomics - nutrigenomics - toxicology testing - others By region: - Asia Pacific - Europe - North America - MEA (Middle East and Africa) - Latin America The separation techniques market is further segmented into capillary electrophoresis, gas chromatography, liquid chromatography (high-performance liquid chromatography and ultra-performance liquid chromatography). The liquid chromatography (high-performance liquid chromatography and ultra-performance liquid chromatography) segment held the largest share of the global metabolomics market in 2021 and is anticipated to hold its share during the forecast period. Furthermore, the detection techniques market has been categorized into mass spectrometry, multivariate analysis, spectroscopy (NMR and FTIR). In 2021, the mass spectrometry segment made up the largest share of revenue generated by the metabolomics market.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Prashant Tiwari

The market research report covers the analysis of key stake holders of the global metabolomics market. Some of the leading players profiled in the report include Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, LECO Corporation, Metabolon Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation, among others. *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES Historical & Forecast Period This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year. Scope of the Report - To analyze and forecast the market size of the global metabolomics market. - To classify and forecast the global metabolomics market based on product, indication, application, region. - To identify drivers and challenges for the global metabolomics market. - To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global metabolomics market. - To identify and analyze the profile of leading players operating in the global metabolomics market. Why Choose This Report - Gain a reliable outlook of the global metabolomics market forecasts from 2022 to 2028 across scenarios. - Identify growth segments for investment. - Stay ahead of competitors through company profiles and market data. - The market estimate for ease of analysis across scenarios in Excel format. - Strategy consulting and research support for three months. - Print authentication provided for the single-user license.

Table of Contents

  • TABLE OF CONTENTS
  • FIGURES AND TABLES
  • PART 1. INTRODUCTION
  • · Report description
  • · Objectives of the study
  • · Market segment
  • · Years considered for the report
  • · Currency
  • · Key target audience
  • PART 2. METHODOLOGY
  • PART 3. EXECUTIVE SUMMARY
  • PART 4. MARKET OVERVIEW
  • · Introduction
  • · Drivers
  • · Restraints
  • · Impact of COVID-19 pandemic
  • PART 5. MARKET BREAKDOWN BY PRODUCT
  • · Assays
  • · Bioinformatics
  • · Detection techniques
  • · Separation techniques
  • PART 6. MARKET BREAKDOWN BY INDICATION
  • · Cancer
  • · Cardiovascular disorders
  • · Inborn errors of metabolism
  • · Neurological disorders
  • · Others
  • PART 7. MARKET BREAKDOWN BY APPLICATION
  • · Biomarker discovery
  • · Drug discovery
  • · Functional genomics
  • · Nutrigenomics
  • · Toxicology testing
  • · Others
  • PART 8. MARKET BREAKDOWN BY REGION
  • · Asia Pacific
  • · Europe
  • · North America
  • · MEA (Middle East and Africa)
  • · Latin America
  • PART 9. KEY COMPANIES
  • · Agilent Technologies Inc.
  • · Bio-Rad Laboratories Inc.
  • · Bruker Corporation
  • · Danaher Corporation
  • · LECO Corporation
  • · Metabolon Inc.
  • · Shimadzu Corporation
  • · Thermo Fisher Scientific Inc.
  • · Waters Corporation
  • *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
  • DISCLAIMER

Why Bonafide Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology
92%
Data Collection Techniques
97%
Our Research Team & Data Sourcing
93%
Data Science & Analytical Tools
81%
Data Visualization & Presentation Skills
86%
Project/ Report Delivery & After Sales Services
88%
Logo

Global Metabolomics Market 2022-2028

Contact usWe are friendly and approachable, give us a call.